Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Trupti Pai"'
Autor:
Vichitra Behel, Vanita Noronha, Anuradha Choughule, Omshree Shetty, Pratik Chandrani, Akhil Kapoor, Suresh Kumar Bondili, Jyoti Bajpai, Rajiv Kumar, Trupti Pai, Munita Bal, Mamta Gurav, Prachi Bapat, Neha Mittal, Santosh Menon, Vijay Patil, Nandini Menon, Amit Dutt, Kumar Prabhash
Publikováno v:
JCO global oncology. 8
PURPOSE Multidisciplinary molecular tumor boards (MTBs) help in interpreting complex genomic data generated by molecular tumor profiling and improve patients' access to targeted therapies. The purpose of this study was to assess the impact of our ins
Autor:
N. Nair, Anuj Verma, Asawari Patil, Akash Sali, Rohini Hawaldar, Sangeeta Desai, Trupti Pai, Sudeep Gupta, Tanuja Shet, Nishtha Sharma, V. Parmar, Amruta Beke
Publikováno v:
Clinical Breast Cancer. 20:382-389
Background Therapeutic decisions in breast carcinoma are being made on the basis of tumor cell proliferation using exorbitant genomic tests. The 2013 St Gallen meeting advocated surrogate definitions for classifying tumors into luminal subtypes on th
Autor:
Gaurav, Chatterjee, Trupti, Pai, Thomas, Hardiman, Kelly, Avery-Kiejda, Rodney J, Scott, Jo, Spencer, Sarah E, Pinder, Anita, Grigoriadis
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-12 (2018)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Lymph node (LN) metastasis is an important prognostic parameter in breast carcinoma, a crucial site for tumour–immune cell interaction and a gateway for further dissemination of tumour cells to other metastatic sites. To gain insight into the under
Publikováno v:
Turkish Journal of Pathology.
Low-grade Oncocytic Tumor (LOT) of kidney is an emerging neoplasm that forms an important differential diagnosis in a spectrum of entities with oncocytic morphology. It has overlapping features with renal oncocytoma and eosinophilic variant of chromo
Publikováno v:
Indian journal of cancer. 57(2)
A histopathology report offers important prognostic and predictive information that helps plan systemic therapy in breast cancer. However, in many cases a pathologist fails to provide relevant information chiefly due to the lack of awareness of the i
Autor:
Anuj, Verma, Santosh, Menon, Bharat, Rekhi, Trupti, Pai, Amita, Maheshwari, Jaya, Ghosh, Sudeep, Gupta, Kedar, Deodhar
Publikováno v:
Indian journal of cancer. 56(4)
Endometrial stromal sarcoma (ESS) is a common uterine mesenchymal malignancy. According to World Health Organisation (WHO) 2014 classification, ESSs are further subdivided into low-grade ESS (LGESS) and high-grade ESS (HGESS). HGESS is defined by the
Publikováno v:
Archives of Pathology & Laboratory Medicine. 142:626-633
Context PathVysion—a US Food and Drug Administration–approved dual-probe human epidermal growth factor receptor (HER2) fluorescence in situ hybridization (FISH) assay—provides the HER2:CEP17 ratio, a centromeric enumeration probe ratio for dete
Publikováno v:
Annals of Diagnostic Pathology. 25:42-47
This is a largest series of 5 cases of lymphoepithelioma-like carcinoma (LEC) of the breast attempting to look at the expression of basal cytokeratins (CKs), human papillomavirus, and Epstein-Barr virus-encoded RNAs in these tumors. Five cases were s
Autor:
Ashwini Budrukkar, Sangeeta Desai, Trupti Pai, Vani Parmar, Sudeep Gupta, Tanuja Shet, Rajendra A. Badwe, Nita S. Nair, Asawari Patil, Rajiv Sarin
Publikováno v:
International Journal of Surgical Pathology. 24:483-489
This study attempted to review the impact of extent of squamous differentiation in 56 infiltrating duct carcinomas (IDC) with squamous differentiation (metaplastic squamous carcinomas [MSC]). Tumors showing 100% squamous elements were labeled as prim
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 63, Iss 2, Pp 194-199 (2020)
Context: HER2/neu testing in breast cancer is a mandate due to availability of trastuzumab, a monoclonal antibody targeted against this biomarker. Dual-color dual-hapten in situ hybridization (D-DISH) is a new test for assessment of HER2/neu gene ove